Effect of endometriosis on prognosis of ovarian clear cell carcinoma: a 10-year retrospective study
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Endometriosis does not appear to be a prognostic factor for ovarian clear cell carcinoma (OCCC) survival. FIGO stage and chemotherapy sensitivity are the key predictors for overall and progression-free survival in OCCC patients.
Area Of Science
- Gynecologic Oncology
- Pathology
- Surgical Oncology
Background
- Endometriosis is a debated precancerous lesion for ovarian clear cell carcinoma (OCCC).
- The prognostic significance of endometriosis in OCCC remains controversial.
- Understanding prognostic factors is crucial for improving OCCC diagnosis and treatment.
Purpose Of The Study
- To evaluate the prognostic significance of endometriosis in OCCC patients.
- To analyze the impact of clinical pathological features on OCCC prognosis.
- To assess the roles of laparoscopic surgery and chemotherapy in OCCC management.
Main Methods
- Retrospective analysis of 105 OCCC patients (2013-2022).
- Patients categorized into endometriosis-positive (44 cases) and endometriosis-negative (61 cases) groups.
- Comparison of clinical pathological characteristics, progression-free survival (PFS), and overall survival (OS).
Main Results
- No significant difference in OS or PFS between endometriosis-positive and -negative groups.
- FIGO stage and chemotherapy efficacy were independent predictors for survival and recurrence.
- Residual tumor, staging, invasion, ascites, and lymph node metastasis predicted recurrence.
Conclusions
- Co-existing endometriosis is not a prognostic factor for OCCC survival.
- FIGO stage and chemotherapy sensitivity are the primary predictors of OS and PFS.
- Further prospective studies are needed to clarify the link between endometriosis and OCCC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
